December 2012

Best Practices in Adherence in the Community Setting

January 31, 2013

Features

Medication nonadherence is a growing issue for patients, clinicians, health care systems, and payers because of mounting evidence that it is prevalent and associated with adverse outcomes and higher costs of care. Here are some best practices to get people to take the medicines prescribed for them.

CMS Revisiting Coverage Policies for Aprepitant and Amyvid

December 18, 2012

Washington Insights

The specialty pharmacy community should remain alert in the coming months as the MEDCAC receives public comments and considers the future of Medicare coverage for 2 major therapies. The MEDCAC decision can have far-reaching impact on patient access.

Advances in Specialty Therapy Nursing

December 18, 2012

Specialty Pharmacy Nursing

Specialty therapy nurses can present educational modules that encompass the disease state, symptoms, diagnosis, and treatment of orphan and ultra orphan disorders.

Gilead Sciences, Inc's Truvada

December 18, 2012

New Drug Review

The FDA approved Gilead Sciences, Inc.'s Truvada (emtricitabine 200 mg/tenofovir disproxil fumarate 300 mg) in combination with safer sex practices for pre-exposure prophylaxis.

Specialty Pharmaceuticals: Manufacturers Must Consider a New Supply Chain

December 18, 2012

Features

Future strategies to manage specialty drugs are geared toward improving overall health care management of patients rather than relying on supply chain cost reduction strategies. The management of specialty drugs requires strategies that focus on outcomes and value.

Specialty Pharmacy in the European Union

December 18, 2012

Features

Recent economic developments in Europe have impacted the state of specialty pharmacy. Here is an overview of the fluid situation and a comparison with the United States specialty market.

Melanoma

December 18, 2012

Disease State Management

A study found that melanoma is more common in immunosuppressed patients, including patients with a prior solid organ transplant, patients with lymphoma, and patients with HIV/AIDS.